LifeMD (LFMD) Stock Price, Quote, News & History | Benzinga

SPY769.86+0.03%QQQ749.55−0.00%BTC/USD86,362.58+1.91%DIA511.70+0.12%GLD380.52+0.10%TLT77.53+0.06%

LifeMD Inc (LFMD) Stock Price, Quote, News & History

LFMDNASDAQ

Trade with Public

Trade with Public

$2.74

-0.11-3.86%

Last update: Oct 2, 6:38 PM

$2.78

-0.07-2.46%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$2.86

Close

$2.74

Volume / Avg.

709.13K / 878.07K

Day Range

$2.73 - $2.94

52 Wk Range

2.56 - 7.32

Market Cap

$134.15M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

34

Short Interest

18.34%

Days to Cover

7.52

Recent LifeMD Inc News

Amazon GLP-1 Program Pressures Hims & Hers Stock

Hims & Hers stock falls as Amazon launches a weight loss program with integrated care, pricing options, and nationwide delivery.

Vandana Singh

Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan

Novo Nordisk launches the first Wegovy subscription program. Save on injections and pills through Ro, WeightWatchers, LifeMD, and more.

Vandana Singh

This Upstart Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Wall Street analysts upgraded PennyMac, LifeMD, Upstart, Circle Internet, and Rocket Companies. See their ratings and price targets on Benzinga.

Avi Kapoor

Uniqure To Rally Around 92%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on top names. See all changes on analyst ratings page.

Avi Kapoor

Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost

Novo Nordisk launches Wegovy weight loss pill in the US, showing up to 17% weight loss, with prices starting near $5 a day and broad pharmacy and telehealth access.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-9.91M

Investing Cash Flow (TTM)

9.78M

Financing Cash Flow (TTM)

-10.96M

Free Cash Flow (TTM)

-18.28M

Capital Expenditure (TTM)

-8.37M

Net Change in Cash (TTM)

-11.09M

Analyst Trends and Forecast

2

May

3

Aug

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$113.10M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.70

PB Ratio (TTM)

17.26

Earnings Yield % (TTM)

-18.60%

Earnings Yield % (FWD)

-4.21%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.17

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$16.67M

Total Cash

$25.14M

Debt to Equity

0.76

Issuance of Debt (TTM)

-$16.67M

Repayment of Debt (TTM)

-$16.67M